n-leucyldoxorubicin has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, DP; Breistøl, K; Fiebig, HH; Fodstad, O; Hendriks, HR; Langdon, SP | 1 |
1 other study(ies) available for n-leucyldoxorubicin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Prodrugs; Transplantation, Heterologous | 1998 |